129 related articles for article (PubMed ID: 8990699)
1. Mastocytosis: new understandings in cutaneous pathophysiology.
Lazarus GS
J Dermatol; 1996 Nov; 23(11):769-72. PubMed ID: 8990699
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis.
Kurosawa M; Amano H; Kanbe N; Akimoto S; Takeuchi Y; Yamashita T; Hashimoto T; Kurimoto F; Miyachi Y
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S25-32. PubMed ID: 9440541
[TBL] [Abstract][Full Text] [Related]
3. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study.
Horny HP; Greschniok A; Jordan JH; Menke DM; Valent P
J Clin Pathol; 2003 Feb; 56(2):103-6. PubMed ID: 12560387
[TBL] [Abstract][Full Text] [Related]
4. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions.
Schechter NM; Wang ZM; Blacher RW; Lessin SR; Lazarus GS; Rubin H
J Immunol; 1994 Apr; 152(8):4062-9. PubMed ID: 8144971
[TBL] [Abstract][Full Text] [Related]
5. Mast-cell phenotype in indolent forms of mastocytosis. Ultrastructural features, fluorescence detection of avidin binding, and immunofluorescent determination of chymase, tryptase, and carboxypeptidase.
Weidner N; Horan RF; Austen KF
Am J Pathol; 1992 Apr; 140(4):847-57. PubMed ID: 1562049
[TBL] [Abstract][Full Text] [Related]
6. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of mast cell chymase and tryptase and of c-Kit in human cutaneous scar tissue.
Hermes B; Feldmann-Böddeker I; Welker P; Algermissen B; Steckelings MU; Grabbe J; Henz BM
J Invest Dermatol; 2000 Jan; 114(1):51-5. PubMed ID: 10620115
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of tryptase in bovine cutaneous and tumor mast cells.
Welle MM; Proske SM; Harvima IT; Schechter NM
J Histochem Cytochem; 1995 Nov; 43(11):1139-44. PubMed ID: 7560896
[TBL] [Abstract][Full Text] [Related]
9. No relationship between histamine release measured as metabolite excretion in the urine, and serum levels of mast cell specific tryptase in mastocytosis.
Granerus G; Lönnqvist B; Roupe G
Agents Actions; 1994 Jun; 41 Spec No():C127-8. PubMed ID: 7526641
[TBL] [Abstract][Full Text] [Related]
10. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand.
Li L; Meng XW; Krilis SA
J Immunol; 1996 Jun; 156(12):4839-44. PubMed ID: 8648132
[TBL] [Abstract][Full Text] [Related]
11. Chronically KIT-stimulated clonally-derived human mast cells show heterogeneity in different tissue microenvironments.
Longley BJ; Tyrrell L; Lu S; Ma Y; Klump V; Murphy GF
J Invest Dermatol; 1997 May; 108(5):792-6. PubMed ID: 9129234
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells.
Schwartz LB; Irani AM; Roller K; Castells MC; Schechter NM
J Immunol; 1987 Apr; 138(8):2611-5. PubMed ID: 3549903
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of tryptase- and chymase-containing mast cells in cutaneous lichen planus.
Harvima IT; Naukkarinen A; Harvima RJ; Aalto ML; Neittaanmäki H; Horsmanheimo M
Acta Derm Venereol; 1991; 71(5):394-8. PubMed ID: 1721758
[TBL] [Abstract][Full Text] [Related]
14. Tryptase and chymase: comparison of extraction and release in two dog mastocytoma lines.
Caughey GH; Lazarus SC; Viro NF; Gold WM; Nadel JA
Immunology; 1988 Feb; 63(2):339-44. PubMed ID: 3127330
[TBL] [Abstract][Full Text] [Related]
15. The role of chymase in ionophore-induced histamine release from human pulmonary mast cells.
Hultsch T; Ennis M; Heidtmann HH
Adv Exp Med Biol; 1988; 240():133-6. PubMed ID: 2469301
[TBL] [Abstract][Full Text] [Related]
16. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase.
Welle M
J Leukoc Biol; 1997 Mar; 61(3):233-45. PubMed ID: 9060446
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
18. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions.
Harvima IT; Haapanen L; Ackermann L; Naukkarinen A; Harvima RJ; Horsmanheimo M
Acta Derm Venereol; 1999 Mar; 79(2):98-104. PubMed ID: 10228625
[TBL] [Abstract][Full Text] [Related]
19. An antibody raised against in vitro-derived human mast cells identifies mature mast cells and a population of cells that are Fc epsilon RI(+), tryptase(-), and chymase(-) in a variety of human tissues.
Qi JC; Li L; Li Y; Moore K; Madigan MC; Katsoulotos G; Krilis SA
J Histochem Cytochem; 2003 May; 51(5):643-53. PubMed ID: 12704212
[TBL] [Abstract][Full Text] [Related]
20. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
Huttunen M; Harvima IT
Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
